Today, in solidarity with the start of Breast Cancer Awareness Month, dedicated team members at St. Luke’s Health-The Woodlands Hospital are proudly wearing pink. This initiative is more than just a visual display; it’s a heartfelt tribute…
The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement in progression-free survival for breast cancer.
Houston Methodist The Woodlands Hospital employees broke out their pink attire today to kick off Breast Cancer Awareness Month. While wearing the iconic pink is a colorful reminder of the fight thousands of patients are battling, it’s also…
This October, FUSIAN is turning sushi pink to support breast cancer awareness. For every roll made with a pink soy wrap, $1 will be donated to the Breast Cancer Fund of Ohio.
Researchers at the University of Vienna have developed fluorescent peptide tracers that can simultaneously visualize and activate the oxytocin receptor. This receptor—also known as the love/bonding hormone receptor—plays a key role in…
This October, FUSIAN is turning sushi pink to support breast cancer awareness. For every roll made with a pink soy wrap, $1 will be donated to the Breast Cancer Fund of Ohio.
Garcelle Beauvais has a multi-faceted career as an actress, executive producer, model, author and reality TV star. But as a woman who wears many hats, the defining role she has recently learned to prioritize is the act of self-care. “Self…
By Katia Hetter, CNN (CNN) — Women who miss their first screening appointment for breast cancer could have a 40% higher long-term risk of dying from the disease, according to a new study. I wanted to understand more about the importance of…
Have you ever wondered how October became the month to raise awareness about breast cancer? Or why people wear pink ribbons for Breast Cancer Awareness Month? We take a look at that history. We also dive into the number of women who get…
Two years ago, when Act 1 of 2023 was passed unanimously, Pennsylvania became the first state in the nation to require insurers to cover supplemental breast cancer screenings such as MRIs and ultrasounds, as well as BRCA-related genetic…
AstraZeneca shares rallied on Wednesday after the U.K. giant and its Japanese partner said the Food and Drug Administration was reviewing one of its drugs to treat breast cancer.
The U.S. Food and Drug Administration has approved Eli Lilly's Inluriyo (imlunestrant), an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor-positive, human epidermal growth factor receptor 2-negative,…
One of Europe's leading oncologists has spoken to FRANCE 24 about how huge advances in technology are helping women who have and are recovering from breast cancer. Doctor Joana Ribeiro from the Gustave Roussy Institute says that, for…